EyePoint, Inc. (EYPT)
3.40
-0.06
(-1.73%)
USD |
NASDAQ |
Oct 09, 16:00
3.40
0.00 (0.00%)
After-Hours: 20:00
EyePoint 30-Day Average Daily Volume : 3.382M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.382M |
| October 08, 2026 | 3.517M |
| October 07, 2026 | 3.517M |
| October 06, 2026 | 3.554M |
| October 05, 2026 | 3.627M |
| October 02, 2026 | 3.808M |
| October 01, 2026 | 3.951M |
| September 30, 2026 | 4.148M |
| September 29, 2026 | 4.575M |
| September 28, 2026 | 6.233M |
| September 25, 2026 | 6.206M |
| September 24, 2026 | 6.172M |
| September 23, 2026 | 6.170M |
| September 22, 2026 | 6.171M |
| September 21, 2026 | 6.081M |
| September 18, 2026 | 6.008M |
| September 17, 2026 | 5.840M |
| September 16, 2026 | 5.689M |
| September 15, 2026 | 5.621M |
| September 14, 2026 | 5.541M |
| September 11, 2026 | 5.514M |
| September 10, 2026 | 5.475M |
| September 09, 2026 | 5.399M |
| September 08, 2026 | 5.356M |
| September 04, 2026 | 5.327M |
| Date | Value |
|---|---|
| September 03, 2026 | 5.313M |
| September 02, 2026 | 5.268M |
| September 01, 2026 | 5.146M |
| August 31, 2026 | 5.090M |
| August 28, 2026 | 5.010M |
| August 27, 2026 | 4.906M |
| August 26, 2026 | 4.758M |
| August 25, 2026 | 4.699M |
| August 24, 2026 | 4.597M |
| August 21, 2026 | 4.495M |
| August 20, 2026 | 4.277M |
| August 19, 2026 | 4.083M |
| August 18, 2026 | 3.853M |
| August 17, 2026 | 3.382M |
| August 14, 2026 | 1.693M |
| August 13, 2026 | 1.659M |
| August 12, 2026 | 1.691M |
| August 11, 2026 | 1.693M |
| August 10, 2026 | 1.677M |
| August 07, 2026 | 1.736M |
| August 06, 2026 | 1.723M |
| August 05, 2026 | 1.678M |
| August 04, 2026 | 1.648M |
| August 03, 2026 | 1.579M |
| July 31, 2026 | 1.572M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ocular Therapeutix, Inc. | 3.236M |
| Eli Lilly & Co. | 2.303M |
| Nuvation Bio, Inc. | 5.318M |
| ANI Pharmaceuticals, Inc. | 406914.5 |
| Corcept Therapeutics, Inc. | 1.436M |